SQURPHARMA · Square Pharmaceuticals PLC
213.80
BDTUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Tk189.61B
PE
7.70
EV/EBITDA
6.1
DIV Yield
5.7%
Payout Ratio
44%
MQV Rating
5Very Weak
As at 17/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Value
- Near Support
- Short Term Trend - Short
Key Fundamentals
EPS 3 yr Growth
32.00%
EBITDA Margin
28.10%
Operating Cashflow
৳23,622m
Free Cash Flow Return
17.90%
ROIC
18.20%
Interest Coverage
90.10
Quick Ratio
10.50
Performance
52 weeks range
Low 198 - 236
Trade Value (12mth)
US$144,445.00
1 week
-0.42%
1 month
-2.86%
YTD
7.82%
1 year
1.81%
All time high
278.67
Additional Data
Shares Outstanding (Fully Diluted)
886m
HALO Sector
Healthcare
Next Company Report Date
01-Sep-27
Next Ex Dividend Date
17-Nov-25
Next Dividend Pay Date
14-Jan-26
Reporting Currency
BDT
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Weak
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Tapan M. A. Chowdhury | Individual |
| Samuel S. Chowdhury | Individual |
| Anjan Chowdhury | Individual |
| Ratna Patra | Individual |
| Kazi Iqbal Harun | Individual |
